Clinical Features of COVID-19 Patients with Different Outcomes in Wuhan: A Retrospective Observational Study
Coronavirus disease 2019 (COVID-19) has caused considerable morbidity and mortality worldwide since December 2019. This retrospective study determined the characteristics and prognostic factors of COVID-19 patients, focusing on inpatients who died or were discharged between 30 December 2019 and 29 F...
Gespeichert in:
| Veröffentlicht in: | BioMed research international 2020, Vol.2020 (2020), p.1-10 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 10 |
|---|---|
| container_issue | 2020 |
| container_start_page | 1 |
| container_title | BioMed research international |
| container_volume | 2020 |
| creator | Pan, Wei Liu, Menglin Luo, Zhen Wan, Jun Xu, Yao Liu, Jianfang Ye, Jing Li, Dan Zhao, Mengmeng Wang, Menglong Ye, Di Wang, Zhen Zhang, Jishou |
| description | Coronavirus disease 2019 (COVID-19) has caused considerable morbidity and mortality worldwide since December 2019. This retrospective study determined the characteristics and prognostic factors of COVID-19 patients, focusing on inpatients who died or were discharged between 30 December 2019 and 29 February 2020 at Renmin Hospital of Wuhan University. Patients’ medical histories, comorbidities, symptoms, signs, laboratory findings, computed tomography (CT) findings, and clinical management were recorded. All 293 patients were divided into the nonsurviving (n=116) and surviving (n=177) groups. The median age was older in the nonsurviving group than in the surviving group; most patients were older than 65 years in the nonsurviving group. The incidence rates of lymphopenia, neutrophilia, and leukocytosis were significantly higher in the nonsurviving group than in the surviving group. More patients in the nonsurviving group had increased levels of nonspecific infection markers, abnormal liver and kidney function, cardiac injury, and blood coagulation abnormalities on admission. Immune and inflammatory responses were more severely disturbed in the nonsurviving group than in the surviving group. The incidence rates of complications during hospitalization were higher in the nonsurviving group than in the surviving group. Cox regression results also showed that older age, symptoms of dyspnea, comorbidities, and complications were all predictors of death. Close monitoring and timely treatment are needed for high-risk COVID-19 patients. |
| doi_str_mv | 10.1155/2020/2138387 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7537706</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A697089652</galeid><sourcerecordid>A697089652</sourcerecordid><originalsourceid>FETCH-LOGICAL-c476t-c65992e9f5545d3f96a388e6bf8caef1ca320e3fcc2a62720e9263db46b3f43a3</originalsourceid><addsrcrecordid>eNqFkc1rFDEYhwdRbKm9eZaAF0HH5nsmHgrL1mqhsKKtHkMm86abMjtZk8yW_vdm2aWlvZhL3pAnT97kV1VvCf5MiBAnFFN8QglrWdu8qA4pI7yWhJOXDzVjB9VxSre4jJZIrOTr6oAxTBVX_LAa5oMfvTUDOgeTpwgJBYfmi98XZzVR6IfJHsac0J3PS3TmnYNY1mgxZRtWBfYj-jMtzfgFzdBPyDGkNdjsN4AWXYK4KefDWOy_8tTfv6leOTMkON7PR9X1-der-ff6cvHtYj67rC1vZK6tFEpRUE4ILnrmlDSsbUF2rrUGHLGGUQzMWUuNpE2pFZWs77jsmOPMsKPqdOddT90Kels6jmbQ6-hXJt7rYLx-ujP6pb4JG90I1jRYFsGHvSCGvxOkrFc-WRgGM0KYkqacKyqkoKqg75-ht2GK5clbSpBGiBLOI3VjBtB-dKHca7dSPZOqwa0qskJ92lG2_GOK4B5aJlhv89bbvPU-74J_3OFLP_bmzv-PfrejoTDgzCNNGGWcsn8Yd7E6</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2451755383</pqid></control><display><type>article</type><title>Clinical Features of COVID-19 Patients with Different Outcomes in Wuhan: A Retrospective Observational Study</title><source>Wiley Open Access</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>PubMed Central Open Access</source><creator>Pan, Wei ; Liu, Menglin ; Luo, Zhen ; Wan, Jun ; Xu, Yao ; Liu, Jianfang ; Ye, Jing ; Li, Dan ; Zhao, Mengmeng ; Wang, Menglong ; Ye, Di ; Wang, Zhen ; Zhang, Jishou</creator><contributor>Xu, Zongli ; Zongli Xu</contributor><creatorcontrib>Pan, Wei ; Liu, Menglin ; Luo, Zhen ; Wan, Jun ; Xu, Yao ; Liu, Jianfang ; Ye, Jing ; Li, Dan ; Zhao, Mengmeng ; Wang, Menglong ; Ye, Di ; Wang, Zhen ; Zhang, Jishou ; Xu, Zongli ; Zongli Xu</creatorcontrib><description>Coronavirus disease 2019 (COVID-19) has caused considerable morbidity and mortality worldwide since December 2019. This retrospective study determined the characteristics and prognostic factors of COVID-19 patients, focusing on inpatients who died or were discharged between 30 December 2019 and 29 February 2020 at Renmin Hospital of Wuhan University. Patients’ medical histories, comorbidities, symptoms, signs, laboratory findings, computed tomography (CT) findings, and clinical management were recorded. All 293 patients were divided into the nonsurviving (n=116) and surviving (n=177) groups. The median age was older in the nonsurviving group than in the surviving group; most patients were older than 65 years in the nonsurviving group. The incidence rates of lymphopenia, neutrophilia, and leukocytosis were significantly higher in the nonsurviving group than in the surviving group. More patients in the nonsurviving group had increased levels of nonspecific infection markers, abnormal liver and kidney function, cardiac injury, and blood coagulation abnormalities on admission. Immune and inflammatory responses were more severely disturbed in the nonsurviving group than in the surviving group. The incidence rates of complications during hospitalization were higher in the nonsurviving group than in the surviving group. Cox regression results also showed that older age, symptoms of dyspnea, comorbidities, and complications were all predictors of death. Close monitoring and timely treatment are needed for high-risk COVID-19 patients.</description><identifier>ISSN: 2314-6133</identifier><identifier>EISSN: 2314-6141</identifier><identifier>DOI: 10.1155/2020/2138387</identifier><identifier>PMID: 33029494</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Publishing Corporation</publisher><subject>Abnormalities ; Analysis ; Blood coagulation ; Cardiovascular disease ; Care and treatment ; Comorbidity ; Complications ; Computed tomography ; Coronaviruses ; COVID-19 ; CT imaging ; Dyspnea ; Fatalities ; Inflammation ; Leukocytosis ; Lymphopenia ; Morbidity ; Neutrophilia ; Observational studies ; Patients ; Respiration ; Signs and symptoms ; Survival ; Viral diseases</subject><ispartof>BioMed research international, 2020, Vol.2020 (2020), p.1-10</ispartof><rights>Copyright © 2020 Zhen Wang et al.</rights><rights>COPYRIGHT 2020 John Wiley & Sons, Inc.</rights><rights>Copyright © 2020 Zhen Wang et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0</rights><rights>Copyright © 2020 Zhen Wang et al. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c476t-c65992e9f5545d3f96a388e6bf8caef1ca320e3fcc2a62720e9263db46b3f43a3</citedby><cites>FETCH-LOGICAL-c476t-c65992e9f5545d3f96a388e6bf8caef1ca320e3fcc2a62720e9263db46b3f43a3</cites><orcidid>0000-0003-4865-783X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537706/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537706/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,882,4010,27904,27905,27906,53772,53774</link.rule.ids></links><search><contributor>Xu, Zongli</contributor><contributor>Zongli Xu</contributor><creatorcontrib>Pan, Wei</creatorcontrib><creatorcontrib>Liu, Menglin</creatorcontrib><creatorcontrib>Luo, Zhen</creatorcontrib><creatorcontrib>Wan, Jun</creatorcontrib><creatorcontrib>Xu, Yao</creatorcontrib><creatorcontrib>Liu, Jianfang</creatorcontrib><creatorcontrib>Ye, Jing</creatorcontrib><creatorcontrib>Li, Dan</creatorcontrib><creatorcontrib>Zhao, Mengmeng</creatorcontrib><creatorcontrib>Wang, Menglong</creatorcontrib><creatorcontrib>Ye, Di</creatorcontrib><creatorcontrib>Wang, Zhen</creatorcontrib><creatorcontrib>Zhang, Jishou</creatorcontrib><title>Clinical Features of COVID-19 Patients with Different Outcomes in Wuhan: A Retrospective Observational Study</title><title>BioMed research international</title><description>Coronavirus disease 2019 (COVID-19) has caused considerable morbidity and mortality worldwide since December 2019. This retrospective study determined the characteristics and prognostic factors of COVID-19 patients, focusing on inpatients who died or were discharged between 30 December 2019 and 29 February 2020 at Renmin Hospital of Wuhan University. Patients’ medical histories, comorbidities, symptoms, signs, laboratory findings, computed tomography (CT) findings, and clinical management were recorded. All 293 patients were divided into the nonsurviving (n=116) and surviving (n=177) groups. The median age was older in the nonsurviving group than in the surviving group; most patients were older than 65 years in the nonsurviving group. The incidence rates of lymphopenia, neutrophilia, and leukocytosis were significantly higher in the nonsurviving group than in the surviving group. More patients in the nonsurviving group had increased levels of nonspecific infection markers, abnormal liver and kidney function, cardiac injury, and blood coagulation abnormalities on admission. Immune and inflammatory responses were more severely disturbed in the nonsurviving group than in the surviving group. The incidence rates of complications during hospitalization were higher in the nonsurviving group than in the surviving group. Cox regression results also showed that older age, symptoms of dyspnea, comorbidities, and complications were all predictors of death. Close monitoring and timely treatment are needed for high-risk COVID-19 patients.</description><subject>Abnormalities</subject><subject>Analysis</subject><subject>Blood coagulation</subject><subject>Cardiovascular disease</subject><subject>Care and treatment</subject><subject>Comorbidity</subject><subject>Complications</subject><subject>Computed tomography</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>CT imaging</subject><subject>Dyspnea</subject><subject>Fatalities</subject><subject>Inflammation</subject><subject>Leukocytosis</subject><subject>Lymphopenia</subject><subject>Morbidity</subject><subject>Neutrophilia</subject><subject>Observational studies</subject><subject>Patients</subject><subject>Respiration</subject><subject>Signs and symptoms</subject><subject>Survival</subject><subject>Viral diseases</subject><issn>2314-6133</issn><issn>2314-6141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>RHX</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqFkc1rFDEYhwdRbKm9eZaAF0HH5nsmHgrL1mqhsKKtHkMm86abMjtZk8yW_vdm2aWlvZhL3pAnT97kV1VvCf5MiBAnFFN8QglrWdu8qA4pI7yWhJOXDzVjB9VxSre4jJZIrOTr6oAxTBVX_LAa5oMfvTUDOgeTpwgJBYfmi98XZzVR6IfJHsac0J3PS3TmnYNY1mgxZRtWBfYj-jMtzfgFzdBPyDGkNdjsN4AWXYK4KefDWOy_8tTfv6leOTMkON7PR9X1-der-ff6cvHtYj67rC1vZK6tFEpRUE4ILnrmlDSsbUF2rrUGHLGGUQzMWUuNpE2pFZWs77jsmOPMsKPqdOddT90Kels6jmbQ6-hXJt7rYLx-ujP6pb4JG90I1jRYFsGHvSCGvxOkrFc-WRgGM0KYkqacKyqkoKqg75-ht2GK5clbSpBGiBLOI3VjBtB-dKHca7dSPZOqwa0qskJ92lG2_GOK4B5aJlhv89bbvPU-74J_3OFLP_bmzv-PfrejoTDgzCNNGGWcsn8Yd7E6</recordid><startdate>2020</startdate><enddate>2020</enddate><creator>Pan, Wei</creator><creator>Liu, Menglin</creator><creator>Luo, Zhen</creator><creator>Wan, Jun</creator><creator>Xu, Yao</creator><creator>Liu, Jianfang</creator><creator>Ye, Jing</creator><creator>Li, Dan</creator><creator>Zhao, Mengmeng</creator><creator>Wang, Menglong</creator><creator>Ye, Di</creator><creator>Wang, Zhen</creator><creator>Zhang, Jishou</creator><general>Hindawi Publishing Corporation</general><general>Hindawi</general><general>John Wiley & Sons, Inc</general><general>Hindawi Limited</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>COVID</scope><scope>CWDGH</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-4865-783X</orcidid></search><sort><creationdate>2020</creationdate><title>Clinical Features of COVID-19 Patients with Different Outcomes in Wuhan: A Retrospective Observational Study</title><author>Pan, Wei ; Liu, Menglin ; Luo, Zhen ; Wan, Jun ; Xu, Yao ; Liu, Jianfang ; Ye, Jing ; Li, Dan ; Zhao, Mengmeng ; Wang, Menglong ; Ye, Di ; Wang, Zhen ; Zhang, Jishou</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c476t-c65992e9f5545d3f96a388e6bf8caef1ca320e3fcc2a62720e9263db46b3f43a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Abnormalities</topic><topic>Analysis</topic><topic>Blood coagulation</topic><topic>Cardiovascular disease</topic><topic>Care and treatment</topic><topic>Comorbidity</topic><topic>Complications</topic><topic>Computed tomography</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>CT imaging</topic><topic>Dyspnea</topic><topic>Fatalities</topic><topic>Inflammation</topic><topic>Leukocytosis</topic><topic>Lymphopenia</topic><topic>Morbidity</topic><topic>Neutrophilia</topic><topic>Observational studies</topic><topic>Patients</topic><topic>Respiration</topic><topic>Signs and symptoms</topic><topic>Survival</topic><topic>Viral diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pan, Wei</creatorcontrib><creatorcontrib>Liu, Menglin</creatorcontrib><creatorcontrib>Luo, Zhen</creatorcontrib><creatorcontrib>Wan, Jun</creatorcontrib><creatorcontrib>Xu, Yao</creatorcontrib><creatorcontrib>Liu, Jianfang</creatorcontrib><creatorcontrib>Ye, Jing</creatorcontrib><creatorcontrib>Li, Dan</creatorcontrib><creatorcontrib>Zhao, Mengmeng</creatorcontrib><creatorcontrib>Wang, Menglong</creatorcontrib><creatorcontrib>Ye, Di</creatorcontrib><creatorcontrib>Wang, Zhen</creatorcontrib><creatorcontrib>Zhang, Jishou</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access Journals</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies & Aerospace Database (1962 - current)</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>Middle East & Africa Database</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Biological Science Journals</collection><collection>ProQuest advanced technologies & aerospace journals</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BioMed research international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pan, Wei</au><au>Liu, Menglin</au><au>Luo, Zhen</au><au>Wan, Jun</au><au>Xu, Yao</au><au>Liu, Jianfang</au><au>Ye, Jing</au><au>Li, Dan</au><au>Zhao, Mengmeng</au><au>Wang, Menglong</au><au>Ye, Di</au><au>Wang, Zhen</au><au>Zhang, Jishou</au><au>Xu, Zongli</au><au>Zongli Xu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical Features of COVID-19 Patients with Different Outcomes in Wuhan: A Retrospective Observational Study</atitle><jtitle>BioMed research international</jtitle><date>2020</date><risdate>2020</risdate><volume>2020</volume><issue>2020</issue><spage>1</spage><epage>10</epage><pages>1-10</pages><issn>2314-6133</issn><eissn>2314-6141</eissn><abstract>Coronavirus disease 2019 (COVID-19) has caused considerable morbidity and mortality worldwide since December 2019. This retrospective study determined the characteristics and prognostic factors of COVID-19 patients, focusing on inpatients who died or were discharged between 30 December 2019 and 29 February 2020 at Renmin Hospital of Wuhan University. Patients’ medical histories, comorbidities, symptoms, signs, laboratory findings, computed tomography (CT) findings, and clinical management were recorded. All 293 patients were divided into the nonsurviving (n=116) and surviving (n=177) groups. The median age was older in the nonsurviving group than in the surviving group; most patients were older than 65 years in the nonsurviving group. The incidence rates of lymphopenia, neutrophilia, and leukocytosis were significantly higher in the nonsurviving group than in the surviving group. More patients in the nonsurviving group had increased levels of nonspecific infection markers, abnormal liver and kidney function, cardiac injury, and blood coagulation abnormalities on admission. Immune and inflammatory responses were more severely disturbed in the nonsurviving group than in the surviving group. The incidence rates of complications during hospitalization were higher in the nonsurviving group than in the surviving group. Cox regression results also showed that older age, symptoms of dyspnea, comorbidities, and complications were all predictors of death. Close monitoring and timely treatment are needed for high-risk COVID-19 patients.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Publishing Corporation</pub><pmid>33029494</pmid><doi>10.1155/2020/2138387</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0003-4865-783X</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2314-6133 |
| ispartof | BioMed research international, 2020, Vol.2020 (2020), p.1-10 |
| issn | 2314-6133 2314-6141 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7537706 |
| source | Wiley Open Access; PubMed Central; Alma/SFX Local Collection; PubMed Central Open Access |
| subjects | Abnormalities Analysis Blood coagulation Cardiovascular disease Care and treatment Comorbidity Complications Computed tomography Coronaviruses COVID-19 CT imaging Dyspnea Fatalities Inflammation Leukocytosis Lymphopenia Morbidity Neutrophilia Observational studies Patients Respiration Signs and symptoms Survival Viral diseases |
| title | Clinical Features of COVID-19 Patients with Different Outcomes in Wuhan: A Retrospective Observational Study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T19%3A27%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20Features%20of%20COVID-19%20Patients%20with%20Different%20Outcomes%20in%20Wuhan:%20A%20Retrospective%20Observational%20Study&rft.jtitle=BioMed%20research%20international&rft.au=Pan,%20Wei&rft.date=2020&rft.volume=2020&rft.issue=2020&rft.spage=1&rft.epage=10&rft.pages=1-10&rft.issn=2314-6133&rft.eissn=2314-6141&rft_id=info:doi/10.1155/2020/2138387&rft_dat=%3Cgale_pubme%3EA697089652%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2451755383&rft_id=info:pmid/33029494&rft_galeid=A697089652&rfr_iscdi=true |